Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nasal solitary chemosensory cells express a repertoire of G protein-coupled “bitter” taste receptors known as type II taste receptors (T2Rs), along with associated signaling proteins like α-gustducin and TRPM5 ion channels. These specialized epithelial sentinel cells extend processes into the mucus layer lining the anterior nasal cavity where they detect potentially harmful substances—including bacterial quorum-sensing molecules, environmental toxins/irritants like denatonium benzoate (“bitter”), cycloheximide, menthol—and trigger rapid protective responses by activating nearby trigeminal nerve fibers. This system provides an early warning mechanism against inhaled threats that may not penetrate deeply enough into tissue to reach traditional nociceptive neurons directly; instead it expands the range of detectable airborne dangers by sampling the surface environment above tight junction barriers within the epithelium. Dysfunction may contribute to increased susceptibility toward respiratory infections or inflammatory conditions.
Drugs/compounds that activate these receptors typically: Bind T2R “bitter” taste GPCRs on SCCs. Trigger intracellular signaling cascades involving α-gustducin G protein, PLCβ2 activation, calcium influx via TRPM5 channels. Resulting signals activate trigeminal nerve endings leading to protective reflexes such as sneezing or altered breathing patterns.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solitary chemosensory cell receptor (nasal) (None established; sometimes abbreviated as SCC receptor in literature, but not standardized.).